Breaking the Gene Therapy Barrier for Life-Threatening Red Blood Cell Disorders

Summary

GlobalData’s report, “Breaking the Gene Therapy Barrier for Life-Threatening Red Blood Cell Disorders” takes a look at gene therapy for the treatment of blood disorders such as beta-thalassemia and sickle cell anemia. An international team of researchers led by scientists at Weill-Cornell Medical College in New York City have designed a novel gene therapy strategy with potentially curative implications for patients with beta-thalassemia and sickle cell anemia. This development represents an important advance in addressing significant unmet market needs regarding the future development of therapeutic products for these two serious red blood cell disorders.

Scope

- Introduction and detail on two red blood cell disorders – sickle cell anemia and beta-thalassemia
- Current gene therapy initiatives for beta-thalassemia and sickle cell anemia
- Challenges to Gene Therapy
- Market Implications

Reasons to buy

- Understand the effectiveness of gene therapy in the treatment of red blood cell disorders
- Get the most up to date gene therapy-based research being carried out for sickle cell anemia and beta-thalassemia

Table Of Contents

1 Table of Contents
1 Table of Contents 1
2 Summary 1
3 Breaking the Gene Therapy Barrier for Life-Threatening Red Blood Cell Disorders 1
3.1 Characteristics of Beta-Thalassemia and Sickle Cell Anemia 1
3.2 Novel Gene Therapy for Beta-Thalassemia and Sickle Cell Anemia 2
3.3 Overcoming Barriers to Gene Therapy 2
3.4 Market Implications 2
4 Appendix 3
4.1 Methodology 3
4.1.1 Coverage 3
4.1.2 Secondary Research 3
4.1.3 Primary Research 3
4.1.4 Expert Panel Validation 4
4.2 Contact Us 4
4.3 Disclaimer 4

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Clare

+1 339 368 6001

Purchase Reports From Reputable Market Research Publishers

Global Regenerative Medicine Industry

Global Regenerative Medicine Industry

  • $ 4 950
  • Industry report
  • June 2014
  • by Global Industry Analysts

This report analyzes the worldwide markets for Regenerative Medicine in US$ Million. The report provides separate comprehensive analytics for the US, Japan, Europe, Asia-Pacific, and Rest of World. Annual ...

Plasma Etching: Market Analysis and Strategic Issues

Plasma Etching: Market Analysis and Strategic Issues

  • $ 2 495
  • Industry report
  • August 2014
  • by Information Network

The future needs in plasma etching will be for ever tighter control of process variability, higher selectivity and less damage. This report addresses the strategic issues impacting both the user and supplie ...

Corneal Graft Rejection - Pipeline Review, H1 2014

Corneal Graft Rejection - Pipeline Review, H1 2014

  • $ 2 000
  • Industry report
  • May 2014
  • by Global Markets Direct

Corneal Graft Rejection - Pipeline Review, H1 2014 Summary Global Markets Direct's, ‘Corneal Graft Rejection - Pipeline Review, H1 2014', provides an overview of the Corneal Graft Rejection's therapeutic ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.